Monitoring Therapy for Patients with Alzheimer's Disease

Abstract

Patients with Alzheimer's disease who undergo treatment of any kind should be monitored eight weeks after initiation of therapy and at least every six months thereafter. (Strength of Recommendation: C, based on expert opinion and extrapolation from drug effectiveness studies)